Search Results - "Pulliam, C.F."

Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients by Mapuskar, K.A., Vasquez Martinez, G., Pulliam, C.F., Petronek, M.S., Steinbach, E.J., Monga, V., Furqan, M., Jetton, J.G., Saunders, D.P., Pearce, A., Davidson, S., Pitre, L., Dunlap, N.E., Fairbanks, R., Lee, C.M., Mott, S.L., Bodeker, K.L., Cl, Huang, Buatti, J.M., Anderson, C.M., Beardsley, R.A., Holmlund, J.T., Zepeda-Orozco, D., Spitz, D.R., Allen, B.G.

“…Head and neck squamous cell carcinoma (HNSCC) patients treated with high-dose cisplatin concurrently with radiotherapy (hdCis-RT) commonly suffer kidney injury…”
Get full text

Diet Supplementation with Soy Protein Isolate, but Not the Isoflavone Genistein, Protects Against Alcohol-Induced Tumor Progression in DEN-Treated Male Mice by Mercer, K E, Pulliam, C F, Hennings, L, Cleves, M A, Jones, E E, Drake, R R, Ronis, M J J

“…Diethylnitrosamine-treated male mice were assigned to 4 groups: a casein-based 35% high fat ethanol liquid diet (EtOH), an EtOH diet made with soy protein…”
Get more information